1-Phenylpiperazine → HCID 19911449, compound
Reaction equation
Cl[CH2:2][CH2:3][CH:4]1[O:8][C:7](=[O:9])[N:6]([C:10]2[CH:15]=[CH:14][CH:13]=[C:12]([Cl:16])[CH:11]=2)[CH2:5]1.[C:17]1([N:23]2[CH2:28][CH2:27][NH:26][CH2:25][CH2:24]2)[CH:22]=[CH:21][CH:20]=[CH:19][CH:18]=1>>[Cl:16][C:12]1[CH:11]=[C:10]([N:6]2[CH2:5][CH:4]([CH2:3][CH2:2][N:26]3[CH2:27][CH2:28][N:23]([C:17]4[CH:22]=[CH:21][CH:20]=[CH:19][CH:18]=4)[CH2:24][CH2:25]3)[O:8][C:7]2=[O:9])[CH:15]=[CH:14][CH:13]=1Participants
3
Procedure
Following the procedure of Example 2, the title compound is prepared from 5-(2-chloroethyl)-3-(3-chlorophenyl)-2-oxazolidinone and 1-phenylpiperazine.
Sources & evidence
- ORD record
- ord-04498c3d065b4079aac6ba0bdea60fe6
- Source dataset
- uspto-grants-1992_02
- Patent number
- US05086055
Reaction notes
Loading…